파마코바이오 주식회사

{
  "address": "경기 성남시",
  "ceo_name": "강성민",
  "certificate": [
    {
      "cert_number": "20120106699",
      "changes": "",
      "disclosure_date": "2012-07-26",
      "first_cert_date": "2012-07-26",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2012-07-26 ~ 2014-07-25"
    },
    {
      "cert_number": "20140108810",
      "changes": "",
      "disclosure_date": "2014-07-30",
      "first_cert_date": "2012-07-26",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2014-07-26 ~ 2016-07-25"
    },
    {
      "cert_number": "20160108594",
      "changes": "",
      "disclosure_date": "2016-07-19",
      "first_cert_date": "2012-07-26",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2016-07-26 ~ 2018-07-25"
    },
    {
      "cert_number": "20180110864",
      "changes": "",
      "disclosure_date": "2018-09-12",
      "first_cert_date": "2012-07-26",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-07-26 ~ 2020-07-25"
    },
    {
      "cert_number": "20200111836",
      "changes": "",
      "disclosure_date": "2020-09-09",
      "first_cert_date": "2012-07-26",
      "no": "5",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-07-26 ~ 2022-07-25"
    },
    {
      "cert_number": "20220803020011",
      "changes": "",
      "disclosure_date": "2022-08-03",
      "first_cert_date": "2012-07-26",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2022-07-26 ~ 2025-07-25"
    },
    {
      "cert_number": "20250923020015",
      "changes": "",
      "disclosure_date": "2025-09-23",
      "first_cert_date": "2012-07-26",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2025-07-26 ~ 2028-07-25"
    }
  ],
  "company_name": "파마코바이오 주식회사",
  "corp_no": "135811-*******",
  "financials": {
    "2022": {
      "capital_stock": 1597500000,
      "cost_of_sales": 970009000,
      "current_assets": 1868495000,
      "current_liabilities": 135164000,
      "gross_profit": 257910000,
      "net_income": -1300537000,
      "net_income_bs": -1300537000,
      "non_current_assets": 714671000,
      "non_current_liabilities": 666609000,
      "non_operating_expenses": 65262000,
      "non_operating_income": 17304000,
      "operating_profit": -1252579000,
      "revenue": 1227919000,
      "sga_expenses": 1510489000,
      "total_assets": 2583166000,
      "total_equity": 1781393000,
      "total_liabilities": 801773000
    },
    "2023": {
      "capital_stock": 1597500000,
      "cost_of_sales": 193961000,
      "current_assets": 885468000,
      "current_liabilities": 2230657000,
      "gross_profit": 19376000,
      "net_income": -3012152000,
      "net_income_bs": -3012152000,
      "non_current_assets": 765583000,
      "non_current_liabilities": 662996000,
      "non_operating_expenses": 114289000,
      "non_operating_income": 11156000,
      "operating_profit": -2909019000,
      "revenue": 213337000,
      "sga_expenses": 2928395000,
      "total_assets": 1651051000,
      "total_equity": -1242602000,
      "total_liabilities": 2893653000
    },
    "2024": {
      "capital_stock": 1597500000,
      "cost_of_sales": 293229000,
      "current_assets": 663779000,
      "current_liabilities": 5086770000,
      "gross_profit": 907656000,
      "net_income": -2794980000,
      "net_income_bs": -2794980000,
      "non_current_assets": 549623000,
      "non_current_liabilities": 177870000,
      "non_operating_expenses": 244476000,
      "non_operating_income": 16533000,
      "operating_profit": -2567037000,
      "revenue": 1200885000,
      "sga_expenses": 3474693000,
      "total_assets": 1213402000,
      "total_equity": -4051238000,
      "total_liabilities": 5264640000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "DDNA0101 석류콜라겐젤리",
  "phone": "031-749-****",
  "years": [
    2024,
    2023,
    2022
  ]
}